Novelwise Pharmaceutical Corporation

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	NCT ID
A Rollover Study of NBM-BMX in Combination With Temozolomide in Patients With Newly Diagnosed Glioblastoma	Neoplasms by Site, brain cancer, brain disorder, central nervous system cancer, central nervous system disorder, neoplasm, nervous system disorder	Recruiting	Phase 1 / Phase 2	2026-05-06	NCT07569042
NBM-BMX Administered Orally to Patients With Solid Tumors or Newly Diagnosed Glioblastoma	Neoplasms by Site, brain cancer, brain disorder, cancer, central nervous system cancer, central nervous system disorder, neoplasm, nervous system disorder	Recruiting	Phase 1 / Phase 2	2026-04-29	NCT06012695
Evaluation of the Safety, Efficacy, and Pharmacokinetics of NBM-BMX in Patients With Metastatic Uveal Melanoma	Disease Attributes, Neoplasm Metastasis, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, Uveal Neoplasms, eye disorder, melanocytic neoplasm, melanoma, neoplasm, neuroendocrine neoplasm, ocular cancer, primitive neuroectodermal tumor, uveal disorder, uveal melanoma	Recruiting	Phase 1 / Phase 2	2025-11-28	NCT07136181

Clinical trials